• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • ResearchMatch (RM)
    • Biomarkers
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
Pfizer’s COVID pill Paxlovid has profound effect in seniors, jury still out for younger adults.

Pfizer’s COVID pill Paxlovid has profound effect in seniors, jury still out for younger adults.

by William Jester | Sep 18, 2022 | Community, Covid, News

A new study is sure to add another layer of intrigue surrounding Pfizer’s COVID-19 pill Paxlovid. In the study, based on data collected from 109,000 patients at a large Israeli health system, the drug appeared highly effective in seniors. Researchers found that those...
Triple Therapy Halved the Risk of Death Among Patients Hospitalized With Severe COVID-19.

Triple Therapy Halved the Risk of Death Among Patients Hospitalized With Severe COVID-19.

by William Jester | Sep 17, 2022 | Community, Covid, News

Hospitalized patients on high-flow oxygen for severe COVID-19 pneumonia were nearly 50 percent less likely to die when baricitinib was added to the antiviral remdesivir and the steroid dexamethasone, according to Rutgers research. “All three of the medications work in...
NJACTS Community Engagement Core COVID-19 Resources

NJACTS Community Engagement Core COVID-19 Resources

by William Jester | Sep 15, 2022 | Community, Covid, News

The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for...
A ‘staggering’ number of people couldn’t get care during the pandemic, poll finds

A ‘staggering’ number of people couldn’t get care during the pandemic, poll finds

by Pamela Dahlen | Sep 3, 2022 | Community, Covid, News

According to a recent poll by NPR, the Robert Wood Johnson Foundation and the Harvard T.H. Chan School of Public Health, among households that had a serious illness in the past year, one in five respondents said they had trouble accessing care during the pandemic. ...
Budget allocates $9 million-plus to bolster ranks of NJ’s mental health professionals

Budget allocates $9 million-plus to bolster ranks of NJ’s mental health professionals

by Pamela Dahlen | Aug 30, 2022 | Community, Covid, News

With adults, teens and kids across the state still depressed and anxious from COVID-19, NJ struggles to find psychiatrists, psychologists and counselors to help them. From clinicians to psychiatrists, New Jersey is in need of more mental health professionals....
« Older Entries
Next Entries »

Recent Posts

  • NJACTS Community Engagement Core Available Services
  • Unveiling the Biomechanical Forces that Drive Scarring.
  • Scientists Discover Class of Crystals With Properties That May Prove Revolutionary.
  • Will Banning Food Dyes Improve Our Health?
  • Backed by Science and Evidence, New Jersey’s Actions Aim to Advance Maternal Health.

Archives

  • 2025
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,290)
  • Covid (987)
  • CTO Events (6)
  • News (2,915)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.